Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytochrome P450-mediated drug interactions.

D A Flockhart1, J R Oesterheld

  • 1Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.

Child and Adolescent Psychiatric Clinics of North America
|February 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.

The pharmacogenomics journal·2016
Same author

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.

Clinical pharmacology and therapeutics·2016
Same author

Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.

Clinical pharmacology and therapeutics·2015
Same author

Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational Approach.

Clinical pharmacology and therapeutics·2015
Same author

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.

British journal of cancer·2014
Same author

Prerequisites to implementing a pharmacogenomics program in a large health-care system.

Clinical pharmacology and therapeutics·2014
Same journal

Reimagining the Behavioral Health Crisis Care Continuum for Youth.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Addressing the Behavioral Health Needs of Special Populations Within the Youth Crisis Care Continuum.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Technology-Enabled Crisis Care for Youth: Bridging the Gap.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Crisis Phone Services.

Child and adolescent psychiatric clinics of North America·2026
Same journal

A Crisis Care Continuum for Children and Adolescents: The Boston Medical Center Model.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Mobile Response and Stabilization Services.

Child and adolescent psychiatric clinics of North America·2026
See all related articles

Child psychiatrists can use cytochrome P450 (CYP) tables to predict drug interactions. Understanding CYP substrates, inducers, and inhibitors is crucial for managing medication clearance and potential adverse events in pediatric patients.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Pediatric Psychiatry

Background:

  • Cytochrome P450 (CYP) enzymes play a critical role in drug metabolism.
  • Drug interactions involving CYP enzymes are common and can significantly alter medication efficacy and safety.
  • Child psychiatrists require accessible tools to navigate complex drug-drug interactions in pediatric populations.

Purpose of the Study:

  • To provide child psychiatrists with essential information on CYP enzyme concepts and drug interactions.
  • To equip clinicians with practical tools, such as CYP tables, for anticipating and managing potential drug interactions.
  • To highlight the dynamic nature of CYP data and the need for continuous updates.

Main Methods:

  • Review of common CYP-based drug interactions relevant to psychiatric medications.

Related Experiment Videos

  • Development of CYP tables to illustrate potential interactions based on enzyme pathways.
  • Identification of resources for clinicians to access current CYP data and drug interaction information.

    • Main Results:

    • CYP tables can help clinicians anticipate drug interactions when multiple medications are prescribed.
    • Understanding whether drugs are substrates, inducers, or inhibitors of specific CYPs is key to predicting altered drug clearance.
    • Rapidly evolving CYP information necessitates ongoing literature review and use of updated online resources.

    Conclusions:

    • Child psychiatrists can leverage CYP information and tools to minimize risks associated with drug-drug interactions.
    • Limiting formularies and utilizing literature tracking programs can aid in predicting and reducing adverse events.
    • Access to current online CYP data is essential for safe and effective pharmacotherapy in children.